Published in Int J Chron Obstruct Pulmon Dis on August 27, 2014
Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey. Int J Chron Obstruct Pulmon Dis (2015) 0.91
Tiotropium Respimat(®) vs. HandiHaler(®) : real-life usage and TIOSPIR trial generalizability. Br J Clin Pharmacol (2015) 0.89
The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients: a protocol for an UNLOCK study from the IPCRG. NPJ Prim Care Respir Med (2016) 0.82
Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Paranasal sinus opacification at MRI in lower airway disease (the HUNT study-MRI). Eur Arch Otorhinolaryngol (2015) 0.78
Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.77
The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease. Oxid Med Cell Longev (2016) 0.76
Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med (2016) 0.76
Characterization of a Mouse Model of Emphysema Induced by Multiple Instillations of Low-Dose Elastase. Front Physiol (2016) 0.76
Incidence, Prevalence, and Mortality Trends in Chronic Obstructive Pulmonary Disease over 2001 to 2011: A Public Health Point of View of the Burden. Can Respir J (2016) 0.75
Manual evaluation of the diaphragm muscle. Int J Chron Obstruct Pulmon Dis (2016) 0.75
What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Impact of Comorbid Ischemic Heart Disease on Short-Term Outcomes of Patients Hospitalized for Acute Exacerbations of COPD. Tanaffos (2015) 0.75
Are interstitial lung abnormalities associated with COPD? A nested case-control study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Phenotypic Variation in Patients with Chronic Obstructive Pulmonary Disease in Primary Care. Biomed Res Int (2016) 0.75
Validity, Reliability, and Responsiveness of the Dutch Version of the London Chest Activity of Daily Living Scale in Patients With Severe COPD. Medicine (Baltimore) (2015) 0.75
A letter in response to impact of acetazolamide use in severe exacerbation of chronic obstructive pulmonary disease requiring invasive mechanical ventilation. Int J Crit Illn Inj Sci (2015) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med (2003) 10.40
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med (2005) 8.86
Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 7.67
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
A randomized study of endobronchial valves for advanced emphysema. N Engl J Med (2010) 6.23
Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med (1998) 6.14
Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90
Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med (2010) 5.70
Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res (2010) 5.17
Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol (2013) 4.89
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J (2005) 4.82
Mortality in COPD: Role of comorbidities. Eur Respir J (2006) 4.14
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J (2008) 4.11
Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med (2009) 3.96
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 3.54
Mortality after hospitalization for COPD. Chest (2002) 3.37
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med (2002) 3.32
Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest (2013) 3.25
Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 3.08
Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors. Am J Respir Crit Care Med (2011) 2.93
Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest (2008) 2.93
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol (2005) 2.92
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med (2010) 2.80
Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol (2013) 2.76
Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest (2005) 2.64
Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax (2011) 2.59
Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest (2005) 2.59
Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 2.55
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J (2005) 2.51
Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax (2011) 2.39
Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest (2008) 2.37
Statin use and risk of COPD exacerbation requiring hospitalization. Am J Med (2013) 2.29
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J (2009) 2.29
Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.29
Mechanistic links between COPD and lung cancer. Nat Rev Cancer (2013) 2.28
Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med (2003) 2.28
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax (2010) 2.26
Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest (1995) 2.22
Anxiety disorders in patients with COPD: a systematic review. Respir Care (2013) 2.21
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.21
Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest (2009) 2.20
Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc (2005) 2.17
Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest (2009) 2.16
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax (2007) 2.05
Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation. Eur Respir J (2013) 2.05
Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J (2007) 2.04
Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 2.02
Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.91
Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry (2010) 1.91
Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. Am J Respir Crit Care Med (2012) 1.87
Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med (2013) 1.82
Statins in COPD: a systematic review. Chest (2009) 1.82
Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J (2005) 1.78
Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol (2013) 1.78
Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med (2006) 1.76
Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med (2002) 1.74
Guidelines on the radical management of patients with lung cancer. Thorax (2010) 1.73
Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med (1990) 1.71
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70
The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. Chest (2011) 1.64
Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD (2013) 1.64
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med (2013) 1.62
Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease. Ann Thorac Surg (2003) 1.61
Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study. Aliment Pharmacol Ther (2012) 1.56
Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology (2009) 1.54
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis (2009) 1.52
Bone loss in inflammatory disorders. J Endocrinol (2009) 1.51
Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). Int J Chron Obstruct Pulmon Dis (2012) 1.50
Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J (2009) 1.48
Peptic ulceration, Helicobacter pylori seropositivity and chronic obstructive pulmonary disease. Respirology (2013) 1.45
Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J (2007) 1.44
COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med (2007) 1.43
Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention. Chest (2013) 1.43
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med (2013) 1.41
Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest (2001) 1.40
Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med (2012) 1.36
The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology (2011) 1.36
Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J (2004) 1.29
The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med (2006) 1.29
Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest (2008) 1.28
Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med (2008) 1.27
Osteoporosis-related kyphosis and impairments in pulmonary function: a systematic review. J Bone Miner Res (2007) 1.22
The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail (2010) 1.20
Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med (2008) 1.16
Impact of pulmonary artery pressure on exercise function in severe COPD. Chest (2009) 1.14
Mortality in COPD: causes, risk factors, and prevention. COPD (2010) 1.14
Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology (2012) 1.13
Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail (2013) 1.13
Chronic renal failure: a neglected comorbidity of COPD. Chest (2009) 1.12
Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999. COPD (2005) 1.12
Co-morbidity in older patients with COPD--its impact on health service utilisation and quality of life, a community study. Age Ageing (2006) 1.12
Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.12
Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. Eur Respir J (2012) 1.12
Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study. Respir Med (2010) 1.11
Impact of comorbidities on COPD-specific health-related quality of life. Respir Med (2012) 1.09
Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis (2007) 1.09